Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Meyer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domainS C Robertson, A N Meyer, K C Hart, et al.
Oncogene|August 5, 2000
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4K C Hart, S C Robertson, M Y Kanemitsu, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998
Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type IP Y d'Avis, S C Robertson, A N Meyer, et al.
Frontiers in Pediatrics|October 9, 2023
Evaluating case management for caregivers of children with spinal muscular atrophy type I and II-an exploratory, controlled, mixed-methods trialJana Willems, Astrid Pechmann, Sabine Wider, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domainS C Robertson, A N Meyer, K C Hart, et al.
Oncogene|August 5, 2000
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4K C Hart, S C Robertson, M Y Kanemitsu, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998
Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type IP Y d'Avis, S C Robertson, A N Meyer, et al.
Frontiers in Pediatrics|October 9, 2023
Evaluating case management for caregivers of children with spinal muscular atrophy type I and II-an exploratory, controlled, mixed-methods trialJana Willems, Astrid Pechmann, Sabine Wider, et al.
Pageof 2